BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 34255389)

  • 1. Serum Succinate/Fumarate Ratio in Patients With Paraganglioma/Pheochromocytoma Attending an Endocrine Oncogenetic Unit.
    Bancel LP; Masso V; Dessein AF; Aubert S; Leteurtre E; Coppin L; Odou MF; Cao CD; Cardot-Bauters C; Pigny P
    J Clin Endocrinol Metab; 2023 Aug; 108(9):2343-2352. PubMed ID: 36848172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma.
    Perez K; Jacene H; Hornick JL; Ma C; Vaz N; Brais LK; Alexander H; Baddoo W; Astone K; Esplin ED; Garcia J; Halperin DM; Kulke MH; Chan JA
    Endocr Relat Cancer; 2022 Sep; 29(9):533-544. PubMed ID: 35731023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.
    Vicha A; Taieb D; Pacak K
    Endocr Relat Cancer; 2014 Jun; 21(3):R261-77. PubMed ID: 24500761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Natural History of Observed SDHx -Related Head and Neck Paragangliomas Using Three-Dimensional Volumetric Tumor Analysis.
    Tooker EL; Wiggins RH; Espahbodi M; Naumer A; Buchmann LO; Greenberg SE; Patel NS
    Otol Neurotol; 2023 Oct; 44(9):931-940. PubMed ID: 37590887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing Precision Oncology in Hereditary Paraganglioma-Pheochromocytoma Syndromes: Integrated Interpretation and Data Sharing of the Germline and Tumor Genomes.
    Rana HQ; Koeller DR; Walker M; Unal B; Levine AS; Chittenden A; Isidro RA; Hayes CP; Manam MD; Buehler RM; Manning DK; Barletta JA; Hornick JL; Garber JE; Ghazani AA; Int2grate Oncology Consortium
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas.
    Li M; Richter S; Mohr H; Drukewitz S; Poser I; Stanke D; Calsina B; Martinez-Montes AM; Quinkler M; Timmers HJLM; Nölting S; Beuschlein F; Remde H; Opocher G; Rapizzi E; Pacak K; Pamporaki C; Robledo M; Liu L; Jiang J; Bornstein SR; Eisenhofer G; Fliedner SMJ; Bechmann N
    Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37902037
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Skefos CM; Brock PL; Blouch E; Greenberg SE
    Endocr Oncol; 2024 Jan; 4(1):e230043. PubMed ID: 38770192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiological Surveillance Screening in Asymptomatic Succinate Dehydrogenase Mutation Carriers.
    Tufton N; Sahdev A; Akker SA
    J Endocr Soc; 2017 Jul; 1(7):897-907. PubMed ID: 29264540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Pepponi M; Berti V; Fasciglione E; Montanini F; Canu L; Hubele F; Abenavoli E; Briganti V; Rapizzi E; Charpiot A; Taieb D; Pacak K; Goichot B; Imperiale A
    Eur J Nucl Med Mol Imaging; 2024 Apr; ():. PubMed ID: 38687372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, Genetics, and Management of 24 Patients With Cardiac Paragangliomas: Experience From a Single Center.
    Shi C; Liu JZ; Zeng ZP; Miao Q; Fang LG; Chen S; Ping F; Sun H; Lu L; Chen LB; Fu Y; Zhao DC; Yu CH; JiaJue RZ; Wang X; Liu XR; Ma GT; Zhang CJ; Pan H; Yang HB; Wang YN; Li M; Li F; Shen ZJ; Liang ZY; Xing XP; Zhu WL
    J Endocr Soc; 2023 Aug; 7(9):bvad093. PubMed ID: 37873498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor subtype 2A expression and genetics in 184 paragangliomas: a single center retrospective observational study.
    Shen Y; Luo Y; Li M; Luo R; Chen L; Gao X; Jiang J; Liu Y; Lu Z; Zhang J
    Endocrine; 2024 Feb; ():. PubMed ID: 38306009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management and outcome of head and neck paragangliomas (HNPGLs): A single centre retrospective study.
    Darrat M; Lau L; Leonard C; Cooke S; Shahzad MA; McHenry C; McCance DR; Hunter SJ; Mullan K; Lindsay JR; Graham U; Bailie N; Hampton S; Rajendran S; Houghton F; Conkey D; Morrison PJ; Johnston PC
    Clin Endocrinol (Oxf); 2024 May; ():. PubMed ID: 38696538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk and tumour spectrum in 172 patients with a germline
    Guerrini-Rousseau L; Masliah-Planchon J; Waszak SM; Alhopuro P; Benusiglio PR; Bourdeaut F; Brecht IB; Del Baldo G; Dhanda SK; Garrè ML; Gidding CEM; Hirsch S; Hoarau P; Jorgensen M; Kratz C; Lafay-Cousin L; Mastronuzzi A; Pastorino L; Pfister SM; Schroeder C; Smith MJ; Vahteristo P; Vibert R; Vilain C; Waespe N; Winship IM; Evans DG; Brugieres L
    J Med Genet; 2022 Jun; 59(11):1123-32. PubMed ID: 35768194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the haemodynamic behaviour of patients undergoing pheochromocytoma and paraganglioma removal: A review.
    Ramachandran R; Rewari V
    Cardiovasc Endocrinol; 2017 Jun; 6(2):73-80. PubMed ID: 31646123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Endocrine Tumors and Associated Syndromes: A Narrative Review for Endocrinologists and Endocrine Surgeons.
    Moore EC; Ioannou L; Ruseckaite R; Serpell J; Ahern S
    Endocr Pract; 2021 Nov; 27(11):1165-1174. PubMed ID: 34265452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Response to Cyclophosphamide, Vincristine, and Dacarbazine Chemotherapy in a Patient with Metastatic Carotid Body Paraganglioma.
    Yamada H; Fukushima T; Kobayashi T; Kanda S; Koizumi T; Iwaya M
    Case Rep Oncol; 2021; 14(3):1827-1833. PubMed ID: 35111016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraganglioma and other tumour detection rates in individuals with SDHx pathogenic variants by age of diagnosis and after the age of 50.
    Greenberg SE; Holman R; Kohlmann W; Buchmann L; Naumer A
    Clin Endocrinol (Oxf); 2021 Sep; 95(3):447-452. PubMed ID: 34255389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome.
    Greenberg SE; Jacobs MF; Wachtel H; Anson A; Buchmann L; Cohen DL; Bonanni M; Bennett B; Naumer A; Schaefer AM; Kohlmann W; Nathanson KL; Else T; Fishbein L
    Genet Med; 2020 Dec; 22(12):2101-2107. PubMed ID: 32741965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
    Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.